skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Gene expression profiling in rat liver treated with compounds inducing phospholipidosis

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [2];  [2];  [3];  [4];  [2]
  1. Development Research Center, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Yodogawa-ku, Osaka, 532-8686 (Japan)
  2. Toxicogenomics Project, National Institute of Biomedical Innovation, Ibaraki, Osaka, 567-0085 (Japan)
  3. Food Safety Commission of Japan, Chiyoda-ku, Tokyo, 100-8989 (Japan)
  4. National Institute of Health Sciences, Setagaya-ku, Tokyo 158-8501 (Japan)

We have constructed a large-scale transcriptome database of rat liver treated with various drugs. In an effort to identify a biomarker for diagnosis of hepatic phospholipidosis, we extracted 78 probe sets of rat hepatic genes from data of 5 drugs, amiodarone, amitriptyline, clomipramine, imipramine, and ketoconazole, which actually induced this phenotype. Principal component analysis (PCA) using these probes clearly separated dose- and time-dependent clusters of treated groups from their controls. Moreover, 6 drugs (chloramphenicol, chlorpromazine, gentamicin, perhexiline, promethazine, and tamoxifen), which were reported to cause phospholipidosis but judged as negative by histopathological examination, were designated as positive by PCA using these probe sets. Eight drugs (carbon tetrachloride, coumarin, tetracycline, metformin, hydroxyzine, diltiazem, 2-bromoethylamine, and ethionamide), which showed phospholipidosis-like vacuolar formation in the histopathology, could be distinguished from the typical drugs causing phospholipidosis. Moreover, the possible induction of phospholipidosis was predictable by the expression of these genes 24 h after single administration in some of the drugs. We conclude that these identified 78 probe sets could be useful for diagnosis of phospholipidosis, and that toxicogenomics would be a promising approach for prediction of this type of toxicity.

OSTI ID:
21140863
Journal Information:
Toxicology and Applied Pharmacology, Vol. 229, Issue 3; Other Information: DOI: 10.1016/j.taap.2008.01.036; PII: S0041-008X(08)00047-1; Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English